|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Megan J. EhretPublisher: Springer Nature Switzerland AG Imprint: Springer Nature Switzerland AG ISBN: 9783032094148ISBN 10: 3032094143 Pages: 128 Publication Date: 21 November 2025 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand We will order this item for you from a manufactured on demand supplier. Table of ContentsIntroduction.- History of LAIs.- Brief guidance on use of LAIs- where are the current guidelines.- Evidence of Effectiveness.- First Generation Antipsychotic LAIs.- Haloperidol.- Fluphenazine.- Aripiprazole Products.- Abilify Maintena.- Abilify Asimtufii.- Aristada (to include Initio).- Paliperidone.- Invega Sustenna.- Invega Trinza.- Invega Hafyera.- Risperidone.- Risperdal Consta (to include information on generic availability).- Perseris.- Uzedy.- Rykindo.- Olanzapine.- Zyprexa Relprevv.- Naltrexone.- Vivitrol.- Buprenorphine.- Sublocade.- Brixadi.- Special Populations.- Pediatrics.- Older Adults.- Pregnancy and Lactation.- Approaching the Patient and Successful Utilization.- Successful discussions.- Clinic set-up.- Pharmacist Administration.- Future of LAIs.- Discussion of future products and where practice is headed.- Conclusion.- Medication Reference Tables.ReviewsAuthor InformationMegan J. Ehret, PharmD, MS, BCPP Professor and Co-Director of Mental Health Program University of Maryland, School of Pharmacy Tab Content 6Author Website:Countries AvailableAll regions |
||||